Expanded Neonatal Metabolic Screen

(Contains: Thyroid Stimulating Hormone (Neonatal), Glucose 6, Phosphate Dehydrogenase n, Neonatal 17 Hydroxyprogesterone, Reactive Immunotrypsin, Neonatal Thyroxine (Neonatal T4), Galactose U.T., Total Galactose, Biotinidase, *Hemoglobin Electrophoresis, Hemoglobin type A ( Hgb. A), Hemoglobin type F (Hgb. F), Hemoglobin type S (Hgb. S), Hemoglobin type C (Hgb. C)
*Amino acids by mass spectrometry, Proline, Alanine., Arginine., Citrulline., Leucine + Isoleucine, Methionine., Glycine.
Ornithine, Phenylalanine, Tyrosine., Valine., Succinylacetone, *Acyl carnitines:, Free., C 10, C 10:1, C 10:2, C 12, C 12:1, C 14, C 14-Hydroxy, C 14:1, C 14:2, C 16, C 16 – Hydroxy, C 16: 1, C 16:1 Hydroxy, C 18, C 18 – Hydroxy, C 18:1, C 18:1 Hydroxy, C 18: 2, C 2, C3, C 3 Dicarboxylic – C 4 – OH, C 4 C 4 Dicarboxylic – C 5 OH C, 8:1, C 5, C 5:1, C 5 – Dicarboxylic, C 6, C 6 – Dicarboxylic, C8
Lysosome Storage Diseases

This study is a set of useful tests for the timely diagnosis of certain congenital metabolic diseases that can be detected before symptoms appear, so the study loses preventive usefulness when it is performed after the neonatal period.

• It is requested that the newborn is not fasting, the sampling is preferably done between 5 to 7 days of life of the baby, not being more tan 30 days.
• The lab staff will take a blood sample